OA2-AM24-ST-26 - Blood donor SARS-CoV-2 Infection and Vaccination is not Associated with Adverse Outcomes in Plasma and Platelet Transfusion Recipients Without Acute COVID-19
Location: 342
Presenting Author: Nareg Roubinian, MD, MPHTM – Kaiser Permanente Northern California Division of Research
Transfusion Service
CE: Zero
Saturday, Oct 19th
1:45 PM - 2:45 PM
OA3-AM24-ST-26 - Comparison of SARS-CoV-2 IgG Antibodies between Convalescent Plasma and Conventional Plasma Units
PL1-SN-27 - Acute Kidney Injury to Evaluate Amustaline/Glutathione Pathogen Reduced Red Cells in Cardiac Surgery: Outcomes of the ReCePI Phase III Clinical Trial
OA2-AM24-SN-23 - Expired Blood Transfusion and Mortality Outcomes in Combat Trauma Patients
Location: 362
Presenting Author: Brian Riley, MA, Major – University of Washington School of Medicine, US Air Force Reserve
Transfusion Service
CE: Zero
Monday, Oct 21st
8:15 AM - 9:15 AM
AM24-MN-02-L - A Multidisciplinary Approach to Delivering Comprehensive Care for Chronically Transfused Children and Adults with Sickle Cell Disease: An Overview of the Vanderbilt Sickle Cell Pathways Experience
OA2-AM24-MN-07 - Evaluation of Coagulopathy in Pediatric Cohort Undergoing Massive Transfusion
Location: 362
Presenting Author: Nathan R. Wilken, MD (he/him/his) – Department of Pathology, Baylor College of Medicine
Transfusion Medicine, Texas Children's Hospital
Transfusion Service
CE: Zero
Monday, Oct 21st
8:15 AM - 9:15 AM
OA3-AM24-MN-07 - No Evidence of Anti-D Alloimmunization After RhD-Positive Apheresis Platelet Transfusion to RhD-Negative Pediatric, Adolescent and Young Adults without RhIg Prophylaxis
OA4-AM24-MN-08 - Red Blood Cell Transfusion During 814,564 Admissions to 24 hospitals: Wide Variability in Transfusion Practice Across Hospitals, Physicians, and Patient Diagnoses
Program Chair: Andrea McGonigle – Associate Medical Director, Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, UCLA Health System
OA2-AM24-MN-23 - Phase IV Trial Of Pathogen-reduced Cryoprecipitate vs. Cryoprecipitated AHF to Lower Operative Transfusions (TOP-CLOT) in Cardiac Surgery
OA3-AM24-MN-23 - Randomized Controlled Trial of Pathogen Reduced Platelets Compared to Non-Pathogen Reduced Platelets for Correction of Viscoelastic Platelet Function Testing in Cardiac Surgery
OA4-AM24-MN-39 - Transfusion-Associated Circulatory Overload (TACO) Among Inpatient U.S. Medicare Beneficiaries Ages 65 and Older,2016-2023:A Claims-based Study